F7 and atherosclerosis: The mechanism involved could rely on gender differences in diabetes-related changes in the progression of atherosclerosis or in more novel risk factors (such as markers of coagulation and inflammation, lipid peroxidation, and endothelial function [41–43] Mansfield and colleagues reported that women had significantly higher factor VII and plasminogen activator inhibitor 1 activity than men [44].